Characteristics and outcomes for pulmonary aspergillosis in critically ill patients without influenza: A 3-year retrospective study
Background: Previous studies have revealed higher mortality rates in patients of severe influenza coinfected with invasive pulmonary aspergillosis (IPA) than in those without the coinfection; nonetheless, the clinical outcome of IPA in critically ill patients without influenza remains unclear. Patie...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-12-01
|
| Series: | Journal of Infection and Public Health |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1876034123003234 |
| _version_ | 1797615913443262464 |
|---|---|
| author | Chien-Ming Chao Chih-Cheng Lai Khee-Siang Chan Chun-Chieh Yang Chin-Ming Chen Chung-Han Ho Hsuan-Fu Ou Wen-Liang Yu |
| author_facet | Chien-Ming Chao Chih-Cheng Lai Khee-Siang Chan Chun-Chieh Yang Chin-Ming Chen Chung-Han Ho Hsuan-Fu Ou Wen-Liang Yu |
| author_sort | Chien-Ming Chao |
| collection | DOAJ |
| description | Background: Previous studies have revealed higher mortality rates in patients of severe influenza coinfected with invasive pulmonary aspergillosis (IPA) than in those without the coinfection; nonetheless, the clinical outcome of IPA in critically ill patients without influenza remains unclear. Patients and methods: This retrospective study was conducted in three institutes. From 2016–2018, all adult patients diagnosed with IPA in the intensive care units (ICUs) were identified. The logistic regression was used to identify the potential risk factors associated with in-hospital mortality in patients with non-influenza IPA. The stratified analysis of IPA patients with and without antifungal therapy was also performed. The final model was established using a forward approach, selecting variables with p-values less than 0.05. Results: Ninety patients were included during the study period, and 63 (70%) were men. The most common comorbidity was diabetes mellitus (n = 24, 27%), followed by solid cancers (n = 22, 24%). Antifungal therapy was administered to 50 (56%) patients, mostly voriconazole (n = 44). The in-hospital mortality rate was 49% (n = 44). Univariate analysis revealed that the risk factors for mortality included daily steroid dose, APACHE II score, SOFA score, C-reactive protein (CRP) level, carbapenem use, antifungal therapy, and caspofungin use. Multiple regression analysis identified four independent risk factors for mortality: age (Odds ratio [OR], 1.052, p = 0.013), daily steroid dose (OR, 1.057, p = 0.002), APACHE II score (OR, 1.094, p = 0.012), and CRP level (OR, 1.007, p = 0.008). Furthermore, the multivariable analysis identified that more physicians would initiate antifungal therapy for patients with prolonged steroid use (p = 0.001), lower white blood cell count (p = 0.021), and higher SOFA score (p = 0.048). Thus, under the selection bias, the independent risk factors for mortality in the antifungal treatment subgroup were daily steroid dose (OR, 1.046, p = 0.001) and CRP (OR, 1.006, p = 0.018), whereas the independent risk factor for mortality in the untreated group became APACHE II score (OR, 1.232, p = 0.007). Conclusions: Patients with IPA had a substantially high mortality. Overall, age, steroid use, APACHE II score, and CRP level were identified as the independent risk factors for mortality in patients in the ICU. |
| first_indexed | 2024-03-11T07:33:43Z |
| format | Article |
| id | doaj.art-3da7f50d904a4b558f41e7c7539b9391 |
| institution | Directory Open Access Journal |
| issn | 1876-0341 |
| language | English |
| last_indexed | 2024-03-11T07:33:43Z |
| publishDate | 2023-12-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Journal of Infection and Public Health |
| spelling | doaj.art-3da7f50d904a4b558f41e7c7539b93912023-11-17T05:25:43ZengElsevierJournal of Infection and Public Health1876-03412023-12-01161220012009Characteristics and outcomes for pulmonary aspergillosis in critically ill patients without influenza: A 3-year retrospective studyChien-Ming Chao0Chih-Cheng Lai1Khee-Siang Chan2Chun-Chieh Yang3Chin-Ming Chen4Chung-Han Ho5Hsuan-Fu Ou6Wen-Liang Yu7Department of Intensive Care Medicine, Chi Mei Medical Center, Liouying, Tainan 73657, Taiwan; Department of Dental Laboratory Technology, Min-Hwei College of Health Care Management, Tainan 73657, TaiwanDivision of Hospital Medicine, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan; School of Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung, TaiwanDepartment of Intensive Care Medicine, Chi Mei Medical Center, Tainan 71004, TaiwanDepartment of Intensive Care Medicine, Chi Mei Medical Center, Tainan 71004, TaiwanDepartment of Intensive Care Medicine, Chi Mei Medical Center, Tainan 71004, TaiwanDepartment of Medical Research, Chi Mei Medical Center, Tainan 71004, Taiwan; Department of Hospital and Health Care Administration, Chia Nan University of Pharmacy & Science, Tainan 71710, TaiwanDepartment of Hospital and Health Care Administration, Chia Nan University of Pharmacy & Science, Tainan 71710, Taiwan; Department of Intensive Care Medicine, Chi Mei Medical Center, Chiali 72263, Tainan, TaiwanDepartment of Intensive Care Medicine, Chi Mei Medical Center, Tainan 71004, Taiwan; Department of Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; Correspondence to: Department of Intensive Care Medicine, Chi Mei Medical Center, 901 Chung Hwa Rd., 71710 Tainan City, Taiwan.Background: Previous studies have revealed higher mortality rates in patients of severe influenza coinfected with invasive pulmonary aspergillosis (IPA) than in those without the coinfection; nonetheless, the clinical outcome of IPA in critically ill patients without influenza remains unclear. Patients and methods: This retrospective study was conducted in three institutes. From 2016–2018, all adult patients diagnosed with IPA in the intensive care units (ICUs) were identified. The logistic regression was used to identify the potential risk factors associated with in-hospital mortality in patients with non-influenza IPA. The stratified analysis of IPA patients with and without antifungal therapy was also performed. The final model was established using a forward approach, selecting variables with p-values less than 0.05. Results: Ninety patients were included during the study period, and 63 (70%) were men. The most common comorbidity was diabetes mellitus (n = 24, 27%), followed by solid cancers (n = 22, 24%). Antifungal therapy was administered to 50 (56%) patients, mostly voriconazole (n = 44). The in-hospital mortality rate was 49% (n = 44). Univariate analysis revealed that the risk factors for mortality included daily steroid dose, APACHE II score, SOFA score, C-reactive protein (CRP) level, carbapenem use, antifungal therapy, and caspofungin use. Multiple regression analysis identified four independent risk factors for mortality: age (Odds ratio [OR], 1.052, p = 0.013), daily steroid dose (OR, 1.057, p = 0.002), APACHE II score (OR, 1.094, p = 0.012), and CRP level (OR, 1.007, p = 0.008). Furthermore, the multivariable analysis identified that more physicians would initiate antifungal therapy for patients with prolonged steroid use (p = 0.001), lower white blood cell count (p = 0.021), and higher SOFA score (p = 0.048). Thus, under the selection bias, the independent risk factors for mortality in the antifungal treatment subgroup were daily steroid dose (OR, 1.046, p = 0.001) and CRP (OR, 1.006, p = 0.018), whereas the independent risk factor for mortality in the untreated group became APACHE II score (OR, 1.232, p = 0.007). Conclusions: Patients with IPA had a substantially high mortality. Overall, age, steroid use, APACHE II score, and CRP level were identified as the independent risk factors for mortality in patients in the ICU.http://www.sciencedirect.com/science/article/pii/S1876034123003234Antifungal therapyAspergillosisIntensive care unitMortalityOutcome |
| spellingShingle | Chien-Ming Chao Chih-Cheng Lai Khee-Siang Chan Chun-Chieh Yang Chin-Ming Chen Chung-Han Ho Hsuan-Fu Ou Wen-Liang Yu Characteristics and outcomes for pulmonary aspergillosis in critically ill patients without influenza: A 3-year retrospective study Journal of Infection and Public Health Antifungal therapy Aspergillosis Intensive care unit Mortality Outcome |
| title | Characteristics and outcomes for pulmonary aspergillosis in critically ill patients without influenza: A 3-year retrospective study |
| title_full | Characteristics and outcomes for pulmonary aspergillosis in critically ill patients without influenza: A 3-year retrospective study |
| title_fullStr | Characteristics and outcomes for pulmonary aspergillosis in critically ill patients without influenza: A 3-year retrospective study |
| title_full_unstemmed | Characteristics and outcomes for pulmonary aspergillosis in critically ill patients without influenza: A 3-year retrospective study |
| title_short | Characteristics and outcomes for pulmonary aspergillosis in critically ill patients without influenza: A 3-year retrospective study |
| title_sort | characteristics and outcomes for pulmonary aspergillosis in critically ill patients without influenza a 3 year retrospective study |
| topic | Antifungal therapy Aspergillosis Intensive care unit Mortality Outcome |
| url | http://www.sciencedirect.com/science/article/pii/S1876034123003234 |
| work_keys_str_mv | AT chienmingchao characteristicsandoutcomesforpulmonaryaspergillosisincriticallyillpatientswithoutinfluenzaa3yearretrospectivestudy AT chihchenglai characteristicsandoutcomesforpulmonaryaspergillosisincriticallyillpatientswithoutinfluenzaa3yearretrospectivestudy AT kheesiangchan characteristicsandoutcomesforpulmonaryaspergillosisincriticallyillpatientswithoutinfluenzaa3yearretrospectivestudy AT chunchiehyang characteristicsandoutcomesforpulmonaryaspergillosisincriticallyillpatientswithoutinfluenzaa3yearretrospectivestudy AT chinmingchen characteristicsandoutcomesforpulmonaryaspergillosisincriticallyillpatientswithoutinfluenzaa3yearretrospectivestudy AT chunghanho characteristicsandoutcomesforpulmonaryaspergillosisincriticallyillpatientswithoutinfluenzaa3yearretrospectivestudy AT hsuanfuou characteristicsandoutcomesforpulmonaryaspergillosisincriticallyillpatientswithoutinfluenzaa3yearretrospectivestudy AT wenliangyu characteristicsandoutcomesforpulmonaryaspergillosisincriticallyillpatientswithoutinfluenzaa3yearretrospectivestudy |